The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression
Abstract
OBJECTIVE: This study was an evaluation of the omega-3 fatty acid docosahexaenoic acid (DHA) for the treatment of major depression. METHOD: Thirty-six depressed patients were randomly assigned to receive DHA, 2 g/day, or placebo for 6 weeks. Response was defined a priori as a > or =50% reduction in the score on the Montgomery-Asberg Depression Rating Scale. Thirty-five participants were evaluable; 18 received DHA, and 17 received placebo. RESULTS: Response rates were 27.8% in the DHA group and 23.5% in the placebo group. The difference in response rates between groups did not reach statistical significance. CONCLUSIONS: This trial failed to show a significant effect of DHA monotherapy in subjects with major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Self-citationDepletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients
Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00206-0 · Cited by 581
Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy
Hibbeln, Jr., & Salem, N. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.1 · Cited by 528
Fenton, W. S., Hibbeln, J., & Knable, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00092-x · Cited by 328
Horrobin, D. F., & Bennett, C. N. (1999) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.1999.0037 · Cited by 221
Function of dietary polyunsaturated fatty acids in the nervous system
Bourre, J. M., Bonneil, M., Clément, M., Dumont, O., Durand, G., Lafont, H., Nalbone, G., & Piciotti, M. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90003-f · Cited by 122
ω3 Fatty Acid Status in Patients with Retinitis pigmentosa
Hoffman, D. R., & Birch, D. G. (1998) · KARGER eBooks · doi:10.1159/000059653 · Cited by 22
Cited by
Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
The health benefits of omega‐3 polyunsaturated fatty acids: a review of the evidence
Ruxton, C. H. S., Reed, S. C., Simpson, M. J. A., & Millington, K. J. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00552.x · Cited by 928
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Metadata
- Authors
- Marangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F. S., & Puryear, L. J.
- Venue
- American Journal of Psychiatry
- Published
- 2003-05-01
- Volume
- 160
- Issue
- 5
- Pages
- 996-998
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2153299553
- Cited by
- 380
- References
- 8
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.